3Khanna Aid. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus[J]. Transplantation, 2000, 70(4): 690-694.
4Jain AB, Kashyap R, Rakela J, et al. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events[J]. Liver Transpl Surg, 1999, 5(2) :144-150.
5Kavanagh D, Morris ST, Northridge DB, et al. Electrocardiogram and outcome following renal transplantation [J]. Nephron, 1999, 81(1) :109-110.
6Kimak E, Ksiazek A, Baranowicz-Gaszczyk I, et al. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterolin post-renal transplant patients[-J]. Ren Fail, 2007, 29(6): 705-712.
7Winfried Siffert. G protein b3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy[-J]. Nephrol Dial Transplant, 2000, 15(9) : 1298-1306.
8Deleuze S, Garrigue V, Delmas S, et al. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine? [J]. Transplant Proc, 2006, 38(7) ..2311-2313.
9Manu M, Tanabe K, Tokumoto T, et al. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience[J]. Transplant Proc, 2000, 32 (7) : 1736- 1738.
10Hayakawa T, Takamura T, Abe T, et al. Association o{ the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism, 2007, 56(1):44-48.
